Skip to main content
Signal8

Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin

$SYRAPress releaseNov 3, 2026, 7:55 AM ETRead the release

Syra Health reported its third consecutive profitable quarter, with record Q3 2026 revenue of $2.6 million, up 52% year-over-year. Gross margin hit a company-record 46.3%, up 1,340 basis points, while EPS swung to $0.02 from a $(0.02) loss and EBITDA turned positive at $301,725. Nine-month operating cash flow reached $975,023 and cash sits at $2.4 million with no long-term debt; the company remains on track for full-year 2026 profitability.

Key figures

Eps
0.02
Revenue
2557295
Guidance
on track to achieve full-year profitability in 2026; expects quarter-to-quarter variability from RFP/contract timing
Revenue Yoy
52%
Ebitda
301725
Net income
344610
Gross margin
46.3%
Workforce revenue
613507
Cash and equivalents
2383413
Net income nine months
835831
Population health revenue
1943788
Gross margin yoy bps change
1340
Operating cash flow nine months
975023

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    SYRA: Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin — AI Analysis | Signal8